Thousands of Vaccinated People in US Infected With COVID-19
New data are the first to indicate how effective COVID-19 vaccines are in real life.
Viral Infections
MPR Weekly Dose Podcast 75
The latest status on the Janssen vaccine; Updated guidance from the National Institutes of Health on COVID-19 antibody treatment; The FDA changes in-person mifepristone dispensing; A prefilled-syringe for Xolair injection is approved; And the AI world comes to colonoscopies.
Mixed Results for Ciclesonide Metered-Dose Inhaler in COVID-19 Study
The multicenter, randomized, double-blind, placebo-controlled study included 400 patients with symptomatic COVID-19 infection.
Merck Halts Molnupiravir Trial in Hospitalized COVID-19 Patients; Outpatient Study to Continue
MOVe-OUT is a placebo-controlled, double-blind phase 2/3 study investigating the efficacy and safety of molnupiravir in non-hospitalized patients.
B.1.1.7 SARS-CoV-2 Variant More Transmissible but Not Linked to More Severe Illness, Death
Second study shows no change in symptoms, disease duration, reinfection rates with B.1.1.7, but reveals multiplicative increase in R1
Moderna COVID-19 Vaccine 90% Effective 6 Months After Second Dose
Company also says vaccine is 95 percent effective against severe cases of the disease
New Drug Product: Cabenuva
This slideshow show drug information for Cabenuva. Click here for the complete Cabenuva monograph.
Lucira Check It Test Kit Available OTC for At-Home COVID-19 Testing
The Lucira Check It COVID-19 test kit utilizes a molecular amplification technology to detect SARS-CoV-2 RNA.
Trial Evaluating Dapagliflozin in Hospitalized COVID-19 Patients Misses Endpoints
The DARE-19 trial evaluated dapagliflozin in addition to standard of care in reducing disease progression, clinical complications and all-cause mortality in 1250 adults hospitalized with COVID-19.
CDC: Risk for Catching Coronavirus From Surfaces Is Low
Agency says the risk for contracting the virus from a contaminated surface is less than 1 in 10,000
